RecruitingNCT06447168
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
Studying Primary biliary cholangitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ipsen
- Principal Investigator
- Ipsen Medical DirectorIpsen
- Enrollment
- 424 target
- Eligibility
- All sexes
- Timeline
- 2024 – 2032
Study locations (30)
- Southern California Research Center, Coronado, California, United States
- Cedars-Sinai Medical Center, Los Angeles, California, United States
- University of California Davis Medical Center, Sacramento, California, United States
- South Denver Gastroenterology,P.C., Englewood, Colorado, United States
- Yale University School of Medicine, New Haven, Connecticut, United States
- Schiff Center for Liver Diseases - University of Miami, Miami, Florida, United States
- Beth Israel Deaconess Medical Center, Liver Research Center, Boston, Massachusetts, United States
- Virtua Center for Liver Disease - Cherry Hill, Cherry Hill, New Jersey, United States
- Northwell Health Inc, Center for Liver Disease and Transplantation, Manhasset, New York, United States
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
- Cleveland Clinic Foundation, Cleveland, Ohio, United States
- Medical University of South Carolina (MUSC), Charleston, South Carolina, United States
- Liver Center of Texas, Dallas, Texas, United States
- Baylor College of Medicine - Advanced Liver Therapies, Houston, Texas, United States
- Gastro health & Nutrition, Katy, Texas, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06447168 on ClinicalTrials.govOther trials for Primary biliary cholangitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07449793Biochemical Response and Clinical Outcomes in Patients With PBCRenJi Hospital
- RECRUITINGPHASE3NCT07296458FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC TherapyXijing Hospital of Digestive Diseases
- RECRUITINGPHASE3NCT07282353A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCACascade Pharmaceuticals, Inc
- RECRUITINGNCT07205874Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)Hospital Universitario La Paz
- ACTIVE NOT RECRUITINGNCT07049887A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria)Ipsen
- RECRUITINGNCT07149675PBC Long-term Outcomes StudyBeijing Friendship Hospital
- RECRUITINGEARLY PHASE1NCT07104201Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)Xijing Hospital of Digestive Diseases
- RECRUITINGNANCT06861465EMPower MechanismsUniversity of Alberta